Cargando…

TCTAP A-014 Pharmacoinvasive Therapy in Treating Acute STEMI Patients in COVID-19 Era-Thrombolysis by Tenecteplase (TNK) / Streptokinase (STK) Followed by Rescue PCI of the Culprit Vessel

Detalles Bibliográficos
Autores principales:	Islam, Ahm Waliul, Reza, A.Q.M., Munwar, Shams, Talukder, Shahab Uddin, Tamzeed Ahmed, Tamzeed Ahmed, Rahman, Kazi Atiqur, Bhuiyan, Azfar Hossain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119550/ http://dx.doi.org/10.1016/j.jacc.2023.03.023

Ejemplares similares

The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
por: Raja, Deep Chandh, et al.
Publicado: (2017)

Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2017)

Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis
por: Kathirvel, D., et al.
Publicado: (2018)

Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase
por: Kiran, G. Ravi, et al.
Publicado: (2021)

Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
por: Bawaskar, Himmatrao S., et al.
Publicado: (2019)

A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries
por: Muoghalu, Chioma G, et al.
Publicado: (2023)

Intra-arterial tenecteplase is safe and may improve the first-pass recanalization for acute ischemic stroke with large-artery atherosclerosis: the BRETIS-TNK trial
por: Zhao, Zi-Ai, et al.
Publicado: (2023)

Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5–24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study
por: Wang, Lu, et al.
Publicado: (2023)

TCTAP C-101 Lost and Found
por: Yong, David, et al.
Publicado: (2022)

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design
por: Levin, Bruce, et al.
Publicado: (2011)

Left ventricular global longitudinal strain following revascularization in acute ST elevation myocardial infarction – A comparison of primary angioplasty and Streptokinase-based pharmacoinvasive strategy
por: Paul, Amal, et al.
Publicado: (2017)

TCTAP C-097 Coronary Perforation With a Twist
por: Loh, Hoong Sheng
Publicado: (2022)

Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction
por: Helal, Ayman M., et al.
Publicado: (2018)

The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity
por: Ahmed, Sultan, et al.
Publicado: (2022)

TCTAP C-101 Role of Echocardiography Where Life is on the Rope©
por: Singha, Chayan
Publicado: (2021)

STREAM at one year: Further evidence supporting a pharmacoinvasive strategy in patients with STEMI
por: ElGuindy, Ahmed M.
Publicado: (2015)

TCTAP A-018 Acute STEMI : Before and During the COVID-19 Pandemic Single Center Study
por: Malik, Fazila, et al.
Publicado: (2023)

STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
por: ElGuindy, Ahmed M.
Publicado: (2014)

Trail Toward Tenecteplase
por: Srivastava, Trilochan, et al.
Publicado: (2022)

Magnetic Field Effects on the Structure, Dielectric and Energy Storage Properties of High-Entropy Spinel Ferrite (La(0.14)Ce(0.14)Mn(0.14)Zr(0.14)Cu(0.14)Ca(0.14)Ni(0.14))Fe(2)O(4)/PVDF Nanocomposites
por: Qiao, Jiale, et al.
Publicado: (2023)

Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial
por: Wang, Hai-bo, et al.
Publicado: (2017)

Expanding Footprints of Biosimilar Tenecteplase
por: Subhash, et al.
Publicado: (2023)

Outcome of thrombolysis with streptokinase in patients with prosthetic valve thrombosis
por: Abbas, Shahid, et al.
Publicado: (2021)

Pharmacoinvasive strategy: An essential tool to avoid the reperfusion paradox in STEMI networks
por: Barriuso, Ignacio, et al.
Publicado: (2021)

Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction
por: Sethi, Rishi, et al.
Publicado: (2023)

TCTAP C-019 OCT Guided Complex PCI Using IVL in Calcific LAD
por: Rapolu, Karnakar
Publicado: (2021)

TCTAP C-178 COVID-19 and Spontaneous Coronary Artery Dissection: Association or Causality
por: Khurana, Akshat
Publicado: (2023)

TCTAP C-038 Multiple Complication After Delayed Treated STEMI in COVID-19 Threatening
por: Tsui, Tung-Lin, et al.
Publicado: (2021)

TCTAP C-012 Stormy Primary Percutaneous Coronary Intervention During COVID-19 Pandemic
por: Lim, Wei Juan, et al.
Publicado: (2022)

Intracoronary tenecteplase in STEMI with massive thrombus
por: Jayagopal, P.B., et al.
Publicado: (2018)

Tenecteplase: Haemorrhagic pericarditis: case report
Publicado: (2020)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
por: Alemseged, Fana, et al.
Publicado: (2021)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity
por: Li, Guangshuo, et al.
Publicado: (2022)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Response to “Pharmacoinvasive strategy: An essential tool to avoid the Reperfusion Paradox in STEMI networks”
por: Gopar-Nieto, Rodrigo, et al.
Publicado: (2021)

P014. Migraine and hypnosis
por: Ardore, Marco, et al.
Publicado: (2015)

PHYSICAL AND IMMUNOLOGICAL DIFFERENCES AMONG STREPTOKINASES
por: Dillon, Hugh C., et al.
Publicado: (1965)

Development of an Immunoaffinity Method for Purification of Streptokinase
por: Karimi, Zohreh, et al.
Publicado: (2012)

Streptokinase: Lack of efficacy: case report
Publicado: (2021)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5s663comguticgajgoh30si27i